ClinicalTrials.govpublic full text
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
pancreatic cancer, adenocarcinoma of the pancreas, stage i pancreatic cancer, stage ii pancreatic cancer, stage iii pancreatic cancer, stage iv pancreatic cancer, recurrent pancreatic cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 851279
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.